This medical device is approved
for use in Japan only.
内視鏡手術支援プログラム 内視鏡手術支援プログラム

FEATURES

AI technology to recognize and highlight the ureters and bladder in real-time during laparoscopic or robotic hysterectomy
  • 01
    Co-developed with the National Cancer Center Japan

    This medical device was jointly developed with the National Cancer Center Hospital East and is officially approved for clinical use in Japan.

  • 02
    Proven to Improve Surgeon Sensitivity

    Studies have demonstrated that using SurVis-Hys improves surgeons’ sensitivity in identifying critical organs.

  • 03
    AI-Powered Detection of Ureters and Bladder in Hysterectomy

    During laparoscopic or robotic hysterectomy, the AI highlights the ureters and bladder in real time — without requiring any injections, dyes, or other invasive procedures.

製品の特長
  • Ureters Highlighted in Light Green
  • Bladder Highlighted in Light Blue

EVIDENCE

Performance evaluation tests demonstrated that
SurVis enhances surgeons’ sensitivity in organ recognition

A multicenter study assessed 16 gynecologists’ recognition sensitivity with and without an AI model.
Surgeons analyzed laparoscopic and robot-assisted hysterectomy videos from 29 centers in Japan.
Sensitivity in identifying the ureter and bladder was compared between surgeons working alone and
those using SurVis-Hys for highlighting. Results showed that SurVis-Hys improved sensitivity by 14.6 points for the ureter and 15.8 points for the bladder.

EVIDENCE

How to Use

Compatible with Existing Laparoscopy Systems

Our software simply connects to existing laparoscopy systems such as da Vinci and Stryker, enabling real-time intraoperative analysis — without requiring any injections, dyes, or other invasive procedures.

How to Use